AstraZeneca from Pharmafile - Journalist Profile

	Profile	Recent Articles on Subject
1	AstraZeneca Pharmafile	AstraZeneca’s Voydeya approved in Japan for PNH treatment - 10 months ago AstraZeneca and Sanofi’s Beyfortus approved in China - 11 months ago FDA approves AstraZeneca and Ionis’s Wainua - 11 months ago AstraZeneca launches health-tech business, Evinova - about 1 year ago FDA approves AstraZeneca’s Truqap plus Faslodex for breast cancer treatment - about 1 year ago AstraZeneca’s Imfinzi meets primary endpoint for liver cancer treatment - about 1 year ago AstraZeneca and Cellectis to collaborate for cell therapy and genomic medicine development - about 1 year ago AstraZeneca’s sBLA for FluMist Quadrivalent accepted by FDA - about 1 year ago AstraZeneca and Daiichi Sankyo’s Enhertu approved in EU for treatment of HER2-mutant NSCLC - about 1 year ago AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan performs well in phase 3 trial - about 1 year ago
2	Sanofi Pharmafile Chases science miracles. Enhances lives. Paris, France ScienceHealthcare	AstraZeneca and Sanofi’s Beyfortus approved in China - 11 months ago
3	Ionis Pharmafile	FDA approves AstraZeneca and Ionis’s Wainua - 11 months ago
4	Cellectis Pharmafile	AstraZeneca and Cellectis to collaborate for cell therapy and genomic medicine development - about 1 year ago
5	Daiichi Sankyo Pharmafile Global pharmaceutical company. Rich legacy. Tokyo, Japan pharmaceuticalsinnovation	AstraZeneca and Daiichi Sankyo’s Enhertu approved in EU for treatment of HER2-mutant NSCLC - about 1 year ago AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan performs well in phase 3 trial - about 1 year ago